Rss

Flu vaccine company Novartis is potentially dangerous, the analysis

Flu vaccine company Novartis is potentially dangerous, the analysis

Flu vaccine company Novartis is potentially dangerous, the analysis

Recently, Italy has banned the sale of flu vaccine company Novartis, referring to her insecurity. A specimen was found foreign particles. Farmgigant represented by CEO Joseph Jimenez made a statement regarding safe vaccine.

According to Reuters, this year, Novartis is faced with similar challenges. Questions have been raised time and again the need to improve the quality of their products. As for the "Italian case", then Jimenez does not report on the timing of the investigation and does not apply with respect to losses incurred by the company.

In turn, the Swiss inspection authorities have suspended the delivery of the two vaccines. But Jimenez is sure other countries do not follow suit. Moreover, the Austrian Ministry of Health recommended to switch to alternative products as a precaution, although the official ban on Novartis vaccine was not introduced.

Deutsche Bank analysts believe that the company in general should reconsider its attitude to the direction, is developing vaccines. Rather pessimistic forecasts. Delays in deliveries, low levels of sales cause investors increasingly doubt the vaccines Novartis.